Clinical Trial Update: Double-Blind, Placebo-Controlled Trial of Ketamine Therapy in Treatment-Resistant Depression (TRD) [Phase 2]

View source ↗

Summary

Phase 2 double-blind, placebo-controlled trial evaluating ketamine therapy for treatment-resistant depression; results were posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Treatment-resistant Depression

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Treatment Resistant Depression | Phase 2 | Status: COMPLETED | Results posted: 2018-04-17